Editor-in-Chief Hatice Kübra Elçioğlu Vice Editors Levent Kabasakal Esra Tatar Online ISSN 2630-6344 Publisher Marmara University Frequency Bimonthly (Six issues / year) Abbreviation J.Res.Pharm. Former Name Marmara Pharmaceutical Journal
Journal of Research in Pharmacy 2021 , Vol 25 , Issue 6
Novel and promising approaches in COVID-19 treatment
Zahra ASEFY1,Hamid RASHIDZADEH2,Ali MOHAMMADI2,Mohammad CHAREHSAZ3,Hande SİPAHİ3,Ahmet AYDIN3,Sinem HELVACIOĞLU3,Rovshan KHALILOV4,Renad Ibragimovich ZHDANOV5,Hossein DANAFAR6,Amir HASANZADEH1,Aziz EFTEKHARI1
1Department of Pharmaceutical Toxicology, Maragheh University of Medical Sciences, Maragheh, Iran
2Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
3Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Yeditepe University, İstanbul, Turkey
4Department of Biophysics and biochemistry, Baku State University, Baku, Azerbaijan
5Russian Institute for Advanced Study, Moscow State Pedagogical University, 1/1, Malaya Pirogovskaya St, Moscow, 119991 Russian Federation
6Institute of Radiation Problems, National Academy of Sciences of Azerbaijan, Baku, Azerbaijan DOI : 10.29228/jrp.68 Novel coronavirus or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe respiratory infectious disease, known as coronavirus disease-19 (COVID-19). Over the past few months, a considerable rise in the incidence rate and prevalence of COVID-19 infection have been witnessed. Considering the high disease burden and rapid spread of the COVID-19 and no effective treatment is currently existing, stem cells, engineered nanobiomaterials, natural killer cells based therapy, RNA metabolites and extracellular vesicles are promising alternatives to tackle devastating epidemic. This review spotlights the applications and potential of above-mentioned methods in the treatment of COVID-19. Keywords : Coronavirus; SARS-CoV-2; nano vaccine; ACE 2; extracellular vesicles
Marmara University